Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
British Journal of Haematology|May 31, 2017
Recent progress in relapsed multiple myeloma therapy: implications for treatment decisionsPhilippe Moreau, Edwin de WitCritical Reviews in Oncology/Hematology|March 23, 2017
How have evolutions in strategies for the treatment of relapsed/refractory multiple myeloma translated into improved outcomes for patients?Pieter Sonneveld, Edwin De Wit, Philippe MoreauClinical Lymphoma, Myeloma & Leukemia|June 12, 2017
New Agents in Multiple Myeloma: An Examination of Safety ProfilesSara Bringhen, Edwin De Wit, Meletios-Athanassios DimopoulosExpert Review of Hematology|February 9, 2018
The multiple myeloma treatment landscape: international guideline recommendations and clinical practice in EuropeMichele Cavo, Evangelos Terpos, Joan Bargay, et al.Cancer|June 19, 2009
Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 studyDavid J Vaughn, Sandy Srinivas, Walter M Stadler, et al.Lancet (London, England)|December 8, 2025
Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trialLaurie H Sehn, Kai Hübel, Stefano Luminari, et al.Pageof 1